Assessment of quality and reliability of YouTube videos for patient and physician education on inflammatory myositis M Joshi, K Jagtap, R Gupta, V Agarwal, R Aggarwal, A Goel, L Gupta Clinical Rheumatology 42 (5), 1339-1349, 2023 | 17 | 2023 |
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys K Jagtap, R Naveen, J Day, P Sen, B Vaidya, A Nune, E Nikiphorou, ... Rheumatology 62 (12), 3838-3848, 2023 | 16 | 2023 |
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys P Sen, N Houshmand, S Moghadam Kia, M Joshi, S Saha, K Jagtap, ... Rheumatology 62 (10), 3291-3301, 2023 | 10 | 2023 |
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys P Sen, Z Griger, J Day, M Joshi, A Nune, E Nikiphorou, S Saha, AL Tan, ... Rheumatology 63 (1), 127-139, 2024 | 8 | 2024 |
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey R Naveen, DR Thakare, M Kuwana, JD Pauling, J Day, M Joshi, I Parodis, ... Rheumatology international 43 (7), 1265-1275, 2023 | 8 | 2023 |
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study B Doskaliuk, N Ravichandran, P Sen, J Day, M Joshi, A Nune, ... Rheumatology international 43 (9), 1651-1664, 2023 | 7 | 2023 |
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study SS Ali, P Sen, J Day, M Joshi, A Nune, E Nikiphorou, S Saha, AL Tan, ... Rheumatology 62 (9), e263-e268, 2023 | 6 | 2023 |
Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys P Sen, R Naveen, N Houshmand, S Moghadam Kia, M Joshi, S Saha, ... Rheumatology, 2023 | 6 | 2023 |
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study L Andreoli, D Lini, K Schreiber, I Parodis, P Sen, N Ravichandran, J Day, ... Rheumatology 63 (5), 1341-1351, 2024 | 3 | 2024 |
Flares of autoimmune rheumatic disease following COVID‐19 infection: Observations from the COVAD study NK Sandhu, N Ravichandraan, A Nune, J Day, P Sen, E Nikiphorou, ... International journal of rheumatic diseases 27 (1), e14961, 2024 | 3 | 2024 |
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study LS Hoff, N Ravichandran, P Sen, J Day, M Joshi, A Nune, E Nikiphorou, ... Rheumatology, keae128, 2024 | 1 | 2024 |
Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study T Chatterjee, N Ravichandran, N Nair, AE Gracia‐Ramos, B Barman, ... Journal of diabetes investigation 15 (1), 131-138, 2024 | 1 | 2024 |
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey S Ahmed, L Gupta, M Kuwana, JD Pauling, J Day, N Ravichandran, ... Rheumatology international 44 (1), 89-97, 2024 | 1 | 2024 |
POS0573 COMORBIDITIES, COMPLEX MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES AMONGAUTOIMMUNE RHEUMATIC DISEASES: DATA FROM THE COVAD STUDY L Gupta, N Ravichandran, V Venerito, M Dey, P Sen, S Saha, AL Tan, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 555-556, 2023 | 1 | 2023 |
INFLAMMAGING IN MUSCLE: THE MISSING LINK BETWEEN SARCOPENIA AND IDIOPATHIC INFLAMMATORY MYOPATHIES K Jagtap, LS Hoff, E Conticini, R Naveen, L Gupta Anti-Aging Eastern Europe 1 (1), 63-72, 2022 | 1 | 2022 |
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune … SS Ali, C Demetriou, I Parodis, AL Tan, A Edgar Gracia-Ramos, M Joshi, ... Rheumatology Advances in Practice, rkae154, 2024 | | 2024 |
COVID-19 Vaccination-related Delayed Adverse Events Among Patients with Systemic Lupus Erythematosus: Results from the COVAD Study M Fathima, B Doskaliuk, J Lindblom, E Nikiphorou, C Wincup, S Saha, ... ARTHRITIS & RHEUMATOLOGY 75, 241-244, 2023 | | 2023 |
UNMET NEED IN GERIATRICS–PATIENT VOICE M Joshi, K Jagtap, V Agarwal, L Gupta Anti-Aging Eastern Europe 2 (2), 118-121, 2023 | | 2023 |
LO-019 Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 vaccination in autoimmune disease (COVAD) study EK Olsson, R Naveen, E Nikiphorou, J Lindblom, S Saha, SS Shaharir, ... Lupus Science & Medicine 10 (Suppl 1), 2023 | | 2023 |
POS0549 BREAKTHROUGH SARS-COV-2 INFECTION IN FULLY VACCINATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY E Kihlgren Olsson, N Ravichandran, E Nikiphorou, J Lindblom, S Saha, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 540-541, 2023 | | 2023 |